Patient-derived Models of Abiraterone- and Enzalutamide-resistant Prostate Cancer Reveal Sensitivity to Ribosome-directed Therapy.
Mitchell G Lawrence,Daisuke Obinata,Shahneen Sandhu,Luke A Selth,Stephen Q Wong,Laura H Porter,Natalie Lister,David Pook,Carmel J Pezaro,David L Goode,Richard J Rebello,Ashlee K Clark,Melissa Papargiris, Jenna Van Gramberg,Adrienne R Hanson,Patricia Banks,Hong Wang,Birunthi Niranjan,Shivakumar Keerthikumar,Shelley Hedwards,Alisee Huglo,Rendong Yang,Christine Henzler,Yingming Li,Fernando Lopez-Campos,Elena Castro,Roxanne Toivanen,Arun Azad,Damien Bolton,Jeremy Goad,Jeremy Grummet,Laurence Harewood,John Kourambas,Nathan Lawrentschuk,Daniel Moon,Declan G Murphy,Shomik Sengupta,Ross Snow,Heather Thorne,Catherine Mitchell,John Pedersen,David Clouston,Sam Norden,Andrew Ryan,Scott M Dehm,Wayne D Tilley,Richard B Pearson,Ross D Hannan,Mark Frydenberg,Luc Furic,Renea A Taylor,Gail P Risbridger European urology（2018）
AI 理解论文
溯源树
样例
